Feasibility of Integrating MEditatioN inTO heaRt Disease (the MENTOR Study): A Phase II Randomized Controlled Trial.
Angela RaoRobert ZecchinPhillip J NewtonScott A ReadJane L PhillipsMichelle DiGiacomoSungwon ChangAlan Robert DennissLouise D HickmanPublished in: The Journal of cardiovascular nursing (2023)
Meditation was considered feasible, with 83% (12/15) of the intervention group completing an average of 3.13 (SD, 2.56) out of 6 group meditation sessions and 5.28 (SD, 8.50) self-guided sessions. Meditation was considered acceptable by patients, clinicians, and health managers. Between-group differences in the number of CR sessions completed favored the intervention group in per-protocol analyses (intervention group vs control group, 12 vs 9 sessions; P = .014), which suggests that meditation may be useful to improve patients' adherence to exercise-based CR program.
Keyphrases
- randomized controlled trial
- end stage renal disease
- newly diagnosed
- ejection fraction
- clinical trial
- phase ii
- chronic kidney disease
- prognostic factors
- public health
- study protocol
- healthcare
- type diabetes
- mental health
- high intensity
- metabolic syndrome
- open label
- pulmonary hypertension
- climate change
- weight loss
- double blind
- social media
- human health
- resistance training